Northwire Canada EditionTuesday, July 14, 2026
Northwire
TKO 9.96 +0.0% MINK 0.105 +0.0% LCE 0.250 +0.0% AEF 0.160 +0.0% BEM 0.090 +0.0% APMI 0.120 +0.0% LIO 0.130 +0.0% KC 0.270 +0.0% NOVA 0.165 +0.0% RIO 2.61 +0.0% FCI 0.390 +0.0% ADE 0.135 +0.0% BCU 0.080 +0.0% SPA 0.305 +0.0% AII 21.24 +0.0% MEK 0.045 +0.0% TKO 9.96 +0.0% MINK 0.105 +0.0% LCE 0.250 +0.0% AEF 0.160 +0.0% BEM 0.090 +0.0% APMI 0.120 +0.0% LIO 0.130 +0.0% KC 0.270 +0.0% NOVA 0.165 +0.0% RIO 2.61 +0.0% FCI 0.390 +0.0% ADE 0.135 +0.0% BCU 0.080 +0.0% SPA 0.305 +0.0% AII 21.24 +0.0% MEK 0.045 +0.0%
M&A / Property

Eshbal Signs with Leading U.S. Food Broker Active Marketing Group to Scale Distribution; Grants Performance Equity

ESBL · Price

Executive Summary

  • Eshbal Functional Food Inc. entered a sales and marketing agreement with Active Marketing Group (AMG) to launch its gluten‑free Barili products across major U.S. retail channels, marking the company’s first scaled entry into the United States.
  • The partnership is supported by AMG’s 37‑year track record and relationships with retailers such as Walmart, Target, and CVS, providing a strong go‑to‑market platform for Eshbal’s “better‑for‑you” product line.
  • Concurrently, Eshbal granted 1,260,000 incentive stock options and 741,000 restricted share units to directors and officers under its Omnibus Incentive Plan, with an exercise price of $0.25 per share.

Key Details

  • Sales & Marketing Agreement
  • AMG will represent Eshbal’s flagship gluten‑free Barili products and additional future SKUs in the U.S. market.
  • Scope includes placement in grocery, natural, mass‑market, online, and specialty retailers nationwide.
  • The agreement is intended to build distribution, brand awareness, and sell‑through for Eshbal’s “better‑for‑you” food category.

  • Strategic Rationale

  • Provides Eshbal with immediate access to AMG’s extensive retailer network (e.g., Walmart, Target, Publix, CVS, Sam’s Club, Meijer).
  • Supports the company’s corporate growth strategy of expanding into the multi‑billion‑dollar gluten‑free market.

  • Equity Compensation

  • Total granted: 1,260,000 incentive stock options (Options) and 741,000 restricted share units (RSUs).
  • Options: Exercise price $0.25 per common share; exercisable for up to five years from grant date.
  • RSUs vesting schedule:
    • 251,520 RSUs – 50 % vest immediately; remaining half in six equal monthly installments over the next 6 months.
    • 490,000 RSUs – vested in equal monthly installments over the next 12 months.
  • Grants were made to certain directors and officers (560,000 Options and 621,520 RSUs).

  • Company Background

  • Reported 2024 revenues of > US$11 million.
  • Positions itself as an innovative, profitable food‑tech company with a broad gluten‑free product portfolio.

Notable Quotes

  • “This partnership marks an important milestone in our go‑to‑market plan for North America… creates a strong foundation for the U.S. launch of Barili and other Eshbal brands.” – Avi Markus, Chief Commercial Officer, Eshbal
  • “Eshbal’s pita delivers the closest experience we’ve seen to traditional bread in a gluten‑free format…” – Todd Grisoff, President, Active Marketing Group

All forward‑looking statements are subject to risks and uncertainties; actual results may differ materially.

Read the original news release →

More from Eshbal Functional Food Inc.